Abstract. The application of antibiotics expanded-spectrum third-generation cephalosporin for the treatment of infectious diseases in hospitals is known contribute to increasing resistance due to the presence of the bla CTX-M gene in the bacteria producing ESBLs. This study was aimed to detect ESBLs, isolate phenotype and bla CTX-M genes on Escherichia coli and Klebsiella pneumoniae collected from H. Adam Malik Central Hospital. Phenotypes of the bacterial were detection using Vitek two compact, while the bla CTX-M genes were detection using polymerase chain reaction technique. The results showed that 85 (100%) isolates were ESBLs consisted of 41(48%) of Escherichia coli, and 44 (52%) of Klebsiella pneumoniae, respectively. bla CTX-M genes were detection in 62 (72.94%) of the isolates which 31 (36.47%) were Escherichia coli, and 31 (36.47%) of the isolates were Klebsiella pneumoniae, respectively. This study indicates the high prevalence of bla CTX-M genes in Escherichia coli and Klebsiella pneumoniea causing bacterial antibiotic resistance.
Introduction
The presence of bla CTX-M gene in bacteria causes resistance to the broad spectrum of cephalosporin groups. ESBLs are enzymes derived from mutated beta-lactamase. This mutation leads to an increase in the enzymatic activity of beta-lactamase to penicillin, cephalosporins, and aztreonam. This resistance mechanism is widespread in the world, with reports of clinical isolates produce these betalactamase are from Europe, Africa, Asia, South America and North America [1, 2] . ESBLs are most commonly produced by Enterobacteriaceae especially Escherichia coli and Klebsiella pneumoniae [3, 4] .
The use of beta-lactam group antibiotics, especially the third generation cephalosporin widely for the treatment of infections in hospitals, is a risk factor for infected by ESBLs 4 . Infection due to ESBL-producing bacteria are increasingly, and it is very difficult to treated since the choice of antibiotics becomes very limited and the emergence of new mutants [6] , consequently this causes antibiotic failure against infectious bacteria [14, 15] .
Escherichia coli and Klebsiella pneumoniae are the primary causes of hospital-related infections and infections in the population (community) [6] . The worldwide increase in ESBL prevalence provides the basis for the importance of detecting ESBL phenotype and bla CTX-M genotypes in ESBLs-producing bacteria indispensable for improved therapeutic management and control of the bacterial transmission. This study aimed to detect ESBLs, and bla CTX-M gene in Escherichia coli and Klebsiella pneumoniae isolates from North Sumatra.
Methods

Bacterial isolates and phenotypic characterization
Sampling is done by purposive sampling based on the data of Germs Pattern of Haji Adam Malik Hospital Medan of the first semester of 2015. Bacterial isolates were collected from routine examination at Diagnostic Laboratory Installation, Microbiology Clinical Unit of Haji Adam Malik Hospital Medan. The phenotypic characterization was done using Vitek two Compact which included antimicrobial susceptibility test and ESBLs phenotyping.
DNA isolation
Isolates with ESBLs phenotype of Escherichia coli and Klebsiella pneumonia were subculture on Mac-Conkey agar and incubated 24 hours at 37°C. DNA isolation was conducted by the freezethaw cycling method, by inserting a bacterial colony into 20 μL aqua-bidest in a microtube and the vortex. The bacterial solution was freezer at -20°C for 10 minutes, followed by heating it at 90°C for 10 minutes using the dry block, freeze-thaw cycling done as six times. The freeze-thawed solution was spin at 13,000 rpm for 5 minutes. The supernatant was separated from cell, and subjected to DNA purification check.
Amplification and detection of CTX-M gene using PCR method
CTX-M gene amplification was performed by PCR technique using specific primer: ATG-TGC-AGY-ACC-AGT-AAR-GTK-ATG-GC forward and TGG-GTR-AAR-TAR-GTS-ACC-AGA-AYC-AGC-GG reverse [7] . Amplify the in PCR solution of 12.5µl master mix green go-Taq, 1μL of forward and reverse primer each, 8.5µL nuclease-free water, and 2μL bacterial DNA. Thermocycling reaction was conducted for denaturation at 94 o C for 2 minutes, extended denaturation at 94 o C for 1 minutes, annealing for 52 o C for 30 sec, extension at 72 o C at 45 sec, and extended extension at 72 o C for 5 minutes, this reaction is 30 cycles. PCR product was visualized in mini gel electrophoresis and documented in UV Reader/Gel Documentation System.
Results and Discussion
Phenotypic characterization
Phenotypic characterization showed that all samples (n = 85) contained ESBLs. The ESBLs phenotype was determined from the results of the antimicrobial susceptibility test according to 2015 Clinical Laboratory Susceptibility Institute standard using Vitek 2 compact. The percentage of antimicrobial susceptibility is presented in Table 1 It seemed that all bacterial isolates were resistant to beta-lactam group antibiotics such as penicillin, cephalosporins, and monobactams, which indicated are carrying ESBLs. A number of isolates resistant to beta-lactamase inhibitors such as amoxicillin/ clavulanic, piperacillin/tazobactam, and cefoperazone/sulbactam acid were lower with the percentage of antimicrobial resistant of 73.0, of 56.4, and of 36.4%, respectively. Interestingly, all isolates were resistant to other classes of antibiotics such as tigecycline, cotrimoxazole, and ciprofloxacin. Saverin et al. [17] study in Surabaya, Indonesia, showed that bla CTX-M gene prevalence was found very high. 65 out of 73 isolates of ESBLs Escherichia coli bore bla CTX-M gene [17] . Another study reported that as much as 50.5% of ESBLs Klebsiella pneumoniae isolates in Tertiary-Referral Hospital, Bali, Indonesia was detected to have the bla CTX-M gene. This study showed the widespread of bla CTX-M ESBLs in Indonesia [18] . The antibiotic application can be pressure for bacterial cell. However, mutations allow them to survive. These bacteria pass through this trait to their offspring, leading to the evolution of resistance. Increased resistance due to mutation may facilitate by high bacterial cell number with short generation time 8 . Phenotypic resistance is expression by the presence of ESBL genes such as bla CTX-M. ESBLproducing bacteria are also often resistant to aminoglycosides, fluoroquinolones, tetracyclines, chloramphenicol, and sulfamethoxazole-trimethoprime [12] .
Amplification of bla CTX-M gene
Amplification of bla CTX-M gene resulted in a 539 bp amplicon in both Escherichia coli and Klebsiella pneumoniae isolates (Figure 1 ) with the percentage of 72.94%. The primer used in this study amplified bla CTX-M gene in bacterial isolates resulted in the 539bp amplicon. It is primer could be used to amplify bla CTX-M gene. Hout et al. [7] using this primer showed that 50% of clinical isolates of the Cambodia Surgical Center collection was detected. Resistance to beta-lactam antibiotics may be due to inactivation of antibiotics by beta-lactamase enzyme, target modification of the penicillin binding protein (PBP), and failure penetration of drug disorders to PBP [15] .
The presence of the bla CTX-M gene in bacteria is responsible for hydrolyzing antibiotics cefotaxime. Resistance may extend to other types of cephalosporin antibiotics [9] . Reported that unlike other countries, bla CTX-M genes were predominant in Europe. Several studies showed that ESBL types produce by Escherichia coli and Klebsiella pneumoniae. It was also reported that the ESBL prevalence increased with the emergence of bla CTX-M type genes [10] . Some researchers suggested that bla CTX-M gene found more common in ESBL isolates compared to that of SHV and TEM [16] .
Today, the emergence of new variants on ESBLs producing microorganisms, especially bla CTX-M suggested the co-resistance involvement of other drug classes during endemics. The presence of the co-resistance is due to the different transmission of resistant gene types in the same clones [11] . Some studies showed that the bla CTX-M genotype is usually found in large plasmids often carrying other resistance genes of other antimicrobial agents including aminoglycosides, fluoroquinolones, chloramphenicol, tetracyclines mainly OXA and TEM [12] .
It was find that 48% of Escherichia coli and 52% of Klebsiella pneumoniae isolates showed to have ESBLs, in which 36.47% of both bacteria was bearing bla CTX-M gene ( Table 2 ). The other 27% of ESBL-producing bacteria might bearing another gene of beta-lactam resistance. The ability of ESBL-producing bacteria to hydrolyze beta-lactam antibiotics most of the due to some mutations in several genes such as TEM and SHV. Such mutations generally occur in the active site of the enzyme causing enzyme activity increases [6] . High prevalence of bla CTX-M genes in Escherichia coli and Klebsiella pneumoniae bacteria may increase the risk of transfer of this resistance gene to an-ESBLs bacteria. This study was the first study in North Sumatra revealing the existence of bla CTX-M in ESBL Escherichia coli and Klebsiella penumoniae, therefore need for the hospital awareness to avoid cross infection through health facilities and paramedics. 
Conclusions
This study showed that prevalence of ESBLs Escherichia coli and Klebsiella pneumoniae is quite high in North Sumatra, Indonesia. All isolates were ESBLs bearing. The molecular detection of the bla CTX-M gene showed that 72.94% of the isolates possessed the gene. However, the remains isolates of ESBLs may bear other genes but bla CTX-M gene.
